Anna Vidal‐Crespo

The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia–Microenvironment Interactions in Chronic Lymphocytic Leukemia

Alba Matas‐Céspedes, Anna Vidal‐Crespo, Vanina Rodríguez et al. · Clinical Cancer Research · 2016 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells

Simon C. Body, Anna Esteve‐Arenys, Hadjer Miloudi et al. · Scientific Reports · 2017 · 44 citations · Full text

Veterinary Medicine, Cell Biology, Hematology +17

Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens

Anna Vidal‐Crespo, Alba Matas‐Céspedes, Vanina Rodríguez et al. · Haematologica · 2019 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib)

Alba Matas‐Céspedes, Vanina Rodríguez, Susana G. Kalko et al. · Clinical Cancer Research · 2014 · 29 citations

Life Sciences, Oncology, Pharmacology +16

Daratumumab, a Novel Human Anti-CD38 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma

Alba Matas‐Céspedes, Anna Vidal‐Crespo, Vanina Rodríguez et al. · Blood · 2012 · 13 citations

Pharmacy, Immunology, Oncology +16